Skip to main content
. 2017 May 19;8(43):73925–73937. doi: 10.18632/oncotarget.18034

Figure 3. The effect of GSK635416A on normal BJ-ET fibroblast cells.

Figure 3

(A) Cytotoxicity of GSK635416A, cisplatin and olaparib treatment in a normal fibroblast cell line, BJ-ET. (Data shown are the mean of three independent experiments, with SEM.) (B) Clonogenic survival of BJ-ET cells cultured in the presence or absence of 2 μM GSK635416A and exposed to different doses of radiation. (Data shown are the mean of five independent experiments, with SD).